Responses
Poster Presentations
Rheumatoid arthritis - prognosis, predictors and outcome
SAT0055 Baricitinib showed rapid and greater reduction in pain compared to adalimumab or placebo in patients with rheumatoid arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.